The Food and Drug Administration approved the treatment MONOVISC, so the makers we-
re able to market it immediately after. The supplement can be injected. It assists synovial
fluid regarding the osteoarthritic joint. After using it, the pain will subside and the joints will
be mobile again.
It is promoted to earthlings who suffer from osteoarthritis regarding the knees. MONOVISC
is the first FDA-approved sole-injection therapy with HA from a source that does not utilize
the animals. The fluid is sterile, see-through, biocompatible, resorbable, and viscoelastic.
It is also made of the semi-gloss-linked sodium hyaluronate (NaHA) & is situated in phosph-
ate saline. Viscosupplementation therapy has been beneficial to America. MONOVISC is n-
on-pyrogenic and it contains so-pure hyaluronan. It's a complicated sugar and it was born in
the glycosaminoglycan group.
The Food and Drug Administration viewed safety and effectiveness data from a clinical study
and it included 369 patients. Those human beings were spread out within 31 centers through-
out the United States and Canada. The research convinced the FDA that MONOVISC adver-
se events stayed so low. No large events occurred so the green light was given.
No comments:
Post a Comment